Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Yokose

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Internal Medicine (Tokyo, Japan)|September 1, 1995
Acute gastric mucosal lesions associated with cytomegalovirus infection in a non-immunocompromised hostN Yokose, Y Tanabe, E An, et al.
Annals of Hematology|January 1, 1996
Autoimmune hemolytic anemia in patients with de novo acute myelocytic leukemiaH Tamura, K Ogata, N Yokose, et al.
Clinical and Experimental Immunology|July 27, 2001
Association between natural killer cell activity and infection in immunologically normal elderly peopleK Ogata, E An, Y Shioi, et al.
British Journal of Cancer|July 2, 1998
Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphomaN Yokose, K Ogata, H Tamura, et al.
Stem Cells (Dayton, Ohio)|August 26, 1998
Repeated cycles of G-CSF-combined postremission chemotherapy for acute myeloid leukemia in a first complete remission: a pilot studyK Ogata, E An, K Kamikubo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1993
[Two cases of acute leukemia with t(6;9) (p23;q34)]T Ito, K Suyama, R Tsukahara, et al.
British Journal of Haematology|March 1, 1994
Assessment of therapeutic potential of interleukin 2 for myelodysplastic syndromesK Ogata, N Yokose, T Ito, et al.
Annals of Hematology|February 1, 1993
Chemotherapy for minimally differentiated acute myeloid leukemia (AML-M0). A report on five cases and review of the literatureN Yokose, K Ogata, T Ito, et al.
British Journal of Haematology|April 1, 1996
Plasma soluble interleukin-2 receptor level in patients with primary myelodysplastic syndromes: a relationship with disease subtype and clinical outcomeK Ogata, N Yokose, E An, et al.
British Journal of Haematology|June 1, 1994
Defective natural killer (NK) cell-mediated cytotoxicity does not imply clonal involvement of NK cells in myelodysplastic syndromesK Ogata, H Fujii, N Yokose, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Internal Medicine (Tokyo, Japan)|September 1, 1995
Acute gastric mucosal lesions associated with cytomegalovirus infection in a non-immunocompromised hostN Yokose, Y Tanabe, E An, et al.
Annals of Hematology|January 1, 1996
Autoimmune hemolytic anemia in patients with de novo acute myelocytic leukemiaH Tamura, K Ogata, N Yokose, et al.
Clinical and Experimental Immunology|July 27, 2001
Association between natural killer cell activity and infection in immunologically normal elderly peopleK Ogata, E An, Y Shioi, et al.
British Journal of Cancer|July 2, 1998
Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphomaN Yokose, K Ogata, H Tamura, et al.
Stem Cells (Dayton, Ohio)|August 26, 1998
Repeated cycles of G-CSF-combined postremission chemotherapy for acute myeloid leukemia in a first complete remission: a pilot studyK Ogata, E An, K Kamikubo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1993
[Two cases of acute leukemia with t(6;9) (p23;q34)]T Ito, K Suyama, R Tsukahara, et al.
British Journal of Haematology|March 1, 1994
Assessment of therapeutic potential of interleukin 2 for myelodysplastic syndromesK Ogata, N Yokose, T Ito, et al.
Annals of Hematology|February 1, 1993
Chemotherapy for minimally differentiated acute myeloid leukemia (AML-M0). A report on five cases and review of the literatureN Yokose, K Ogata, T Ito, et al.
British Journal of Haematology|April 1, 1996
Plasma soluble interleukin-2 receptor level in patients with primary myelodysplastic syndromes: a relationship with disease subtype and clinical outcomeK Ogata, N Yokose, E An, et al.
British Journal of Haematology|June 1, 1994
Defective natural killer (NK) cell-mediated cytotoxicity does not imply clonal involvement of NK cells in myelodysplastic syndromesK Ogata, H Fujii, N Yokose, et al.
Pageof 3